APA (7th ed.) Citation

I, R., D, C., MR, M., A, R., C, R., N, C., . . . A, d. B. (2020). Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer. International journal of cancer, 146(2), 439. https://doi.org/10.1002/ijc.32606

Chicago Style (17th ed.) Citation

I, Ray-Coquard, et al. "Final Results from GCIG/ENGOT/AGO-OVAR 12, a Randomised Placebo-controlled Phase III Trial of Nintedanib Combined with Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer." International Journal of Cancer 146, no. 2 (2020): 439. https://doi.org/10.1002/ijc.32606.

MLA (9th ed.) Citation

I, Ray-Coquard, et al. "Final Results from GCIG/ENGOT/AGO-OVAR 12, a Randomised Placebo-controlled Phase III Trial of Nintedanib Combined with Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer." International Journal of Cancer, vol. 146, no. 2, 2020, p. 439, https://doi.org/10.1002/ijc.32606.